DEC 07, 2021 8:00 AM PST

T Cells in COVID-19 - Translating research findings into clinical options

Sponsored by: Miltenyi Biotec
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract
Date:  December 7, 2021
Time: 8:00am (PST),  11:00am (EST)
 
Analysis of SARS-CoV-2–specific T cells is important to understand their role during acute disease and in long-term protection after infection or vaccination. Though studying these rare cells comes with challenges, gained insights offer great opportunities in fighting COVID-19. This webinar will cover both sides.
 
There is growing evidence that SARS-CoV-2–specific T cells play an important role in the recovery from COVID-19. Researchers have reported the presence of a SARS-CoV-2–specific memory T cell population in the blood of convalescent donors. These cells could be used for treating COVID-19 patients in certain cases.
 
At Miltenyi Biotec, we offer a complete workflow for the study of virus-specific T cells. Also, several preparation methods for clinical-grade cell products using our CliniMACS® Technology have been described.1-3 In 2021, Antonio Perez et al. reported improvement of symptoms in nine patients in a phase 1 clinical trial using convalescent donor-derived CD45RA-depleted memory T cells. The study indicates the potential of adoptive cell therapy to treat COVID-19.4 More research is needed to further develop this new exciting field of cell therapy.
 
1 Cooper et al. (2021) Front. Immunol. 11: 598402. 2 Leung et al. (2020) Adv. Cell Gene Ther. 2020: e101. 3 Ferreras et al. (2021) Front. Cell Dev. Biol. 9: 620730. 4 Pérez-Martínez et al. (2021) EClinicalMedicine 39: 101086.
 
Learning Objectives
  • Review tools for SARS-CoV-2–specific T cell research
  • Discuss how to overcome key challenges, such as high sample numbers, low cell frequencies, inefficient stimulation, and operator safety
  • Review published preclinical and clinical data on cell therapy for COVID-19
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
NOV 09, 2022 8:00 AM PST
C.E. CREDITS
NOV 09, 2022 8:00 AM PST
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
Loading Comments...
Show Resources